These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 21138529)

  • 1. Gastrin-releasing peptide receptor antagonist or N-acetylcysteine combined with omeprazol protect against mitochondrial complex II inhibition in a rat model of gastritis.
    Rezin GT; Petronilho FC; Araújo JH; Gonçalves CL; Daufenbach JF; Cardoso MR; Roesler R; Schwartsmann G; Dal-Pizzol F; Streck EL
    Basic Clin Pharmacol Toxicol; 2011 Mar; 108(3):214-9. PubMed ID: 21138529
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of a gastrin-releasing peptide receptor antagonist and a proton pump inhibitor association in an animal model of gastritis.
    Petronilho F; Araújo JH; Steckert AV; Rezin GT; Ferreira GK; Roesler R; Schwartsmann G; Dal-Pizzol F; Streck EL
    Peptides; 2009 Aug; 30(8):1460-5. PubMed ID: 19505518
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of an antagonist of the gastrin-releasing peptide receptor in an animal model of uveitis.
    Pereira DV; Steckert AV; Mina F; Petronilho F; Roesler R; Schwartsmann G; Ritter C; Dal-Pizzol F
    Invest Ophthalmol Vis Sci; 2009 Nov; 50(11):5300-3. PubMed ID: 19516017
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A gastrin-releasing peptide receptor antagonist blocks D-amphetamine-induced hyperlocomotion and increases hippocampal NGF and BDNF levels in rats.
    Kauer-Sant'Anna M; Andreazza AC; Valvassori SS; Martins MR; Barbosa LM; Schwartsmann G; Roesler R; Quevedo J; Kapczinski F
    Peptides; 2007 Jul; 28(7):1447-52. PubMed ID: 17629354
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Non-associative learning and anxiety in rats treated with a single systemic administration of the gastrin-releasing peptide receptor antagonist RC-3095.
    Martins MR; Reinke A; Valvassori SS; Machado RA; Quevedo J; Schwartsmann G; Roesler R
    Peptides; 2005 Dec; 26(12):2525-9. PubMed ID: 16023260
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of the antiulcerogenic activity of Maytenus robusta (Celastraceae) in different experimental ulcer models.
    de Andrade SF; Lemos M; Comunello E; Noldin VF; Filho VC; Niero R
    J Ethnopharmacol; 2007 Sep; 113(2):252-7. PubMed ID: 17629427
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Docosahexaenoic acid, an omega-3 polyunsaturated acid protects against indomethacin-induced gastric injury.
    Pineda-Peña EA; Jiménez-Andrade JM; Castañeda-Hernández G; Chávez-Piña AE
    Eur J Pharmacol; 2012 Dec; 697(1-3):139-43. PubMed ID: 23063544
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Opposite effects of low and high doses of the gastrin-releasing peptide receptor antagonist RC-3095 on memory consolidation in the hippocampus: possible involvement of the GABAergic system.
    Dantas Ados S; Luft T; Henriques JA; Schwartsmann G; Roesler R
    Peptides; 2006 Sep; 27(9):2307-12. PubMed ID: 16650508
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Oxidative stress and metabolism in animal model of colitis induced by dextran sulfate sodium.
    Damiani CR; Benetton CA; Stoffel C; Bardini KC; Cardoso VH; Di Giunta G; Pinho RA; Dal-Pizzol F; Streck EL
    J Gastroenterol Hepatol; 2007 Nov; 22(11):1846-51. PubMed ID: 17489966
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of mood stabilizers on mitochondrial respiratory chain activity in brain of rats treated with d-amphetamine.
    Valvassori SS; Rezin GT; Ferreira CL; Moretti M; Gonçalves CL; Cardoso MR; Streck EL; Kapczinski F; Quevedo J
    J Psychiatr Res; 2010 Oct; 44(14):903-9. PubMed ID: 20334877
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibitory effect of bombesin/gastrin-releasing peptide antagonist RC-3095 and high dose of somatostatin analogue RC-160 on nitrosamine-induced pancreatic cancers in hamsters.
    Szepeshazi K; Schally AV; Cai RZ; Radulovic S; Milovanovic S; Szoke B
    Cancer Res; 1991 Nov; 51(21):5980-6. PubMed ID: 1682039
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibitory effects of somatostatin analogue RC-160 and bombesin/gastrin-releasing peptide antagonist RC-3095 on the growth of the androgen-independent Dunning R-3327-AT-1 rat prostate cancer.
    Pinski J; Reile H; Halmos G; Groot K; Schally AV
    Cancer Res; 1994 Jan; 54(1):169-74. PubMed ID: 7903203
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of N-acetylcysteine/deferoxamine, taurine and RC-3095 on respiratory chain complexes and creatine kinase activities in rat brain after sepsis.
    Cassol OJ; Rezin GT; Petronilho FC; Scaini G; Gonçalves CL; Ferreira GK; Roesler R; Schwartsmann G; Dal-Pizzol F; Streck EL
    Neurochem Res; 2010 Apr; 35(4):515-21. PubMed ID: 20238483
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of the protective effects of various antiulcer agents alone or in combination on indomethacin-induced gastric ulcers in rats.
    Izzettin FV; Sancar M; Okuyan B; Apikoglu-Rabus S; Cevikbas U
    Exp Toxicol Pathol; 2012 May; 64(4):339-43. PubMed ID: 21030227
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impairments of social behavior and memory after neonatal gastrin-releasing peptide receptor blockade in rats: Implications for an animal model of neurodevelopmental disorders.
    Presti-Torres J; de Lima MN; Scalco FS; Caldana F; Garcia VA; Guimarães MR; Schwartsmann G; Roesler R; Schröder N
    Neuropharmacology; 2007 Mar; 52(3):724-32. PubMed ID: 17097693
    [TBL] [Abstract][Full Text] [Related]  

  • 16. YM022 [(R)-1-[2,3-dihydro-1-(2'-methylphenacyl)-2-oxo-5-phenyl- 1H-1,4-benzodiazepin-3-yl]-3-(3-methylphenyl)urea], a potent and selective gastrin/cholecystokinin-B receptor antagonist, prevents gastric and duodenal lesions in rats.
    Nishida A; Takinami Y; Yuki H; Kobayashi A; Akuzawa S; Kamato T; Ito H; Yamano M; Nagakura Y; Miyata K
    J Pharmacol Exp Ther; 1994 Sep; 270(3):1256-61. PubMed ID: 7932178
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of an antagonist of the bombesin/gastrin-releasing peptide receptor on complete Freund's adjuvant-induced arthritis in rats.
    Oliveira PG; Brenol CV; Edelweiss MI; Brenol JC; Petronilho F; Roesler R; Dal-Pizzol F; Schwartsmann G; Xavier RM
    Peptides; 2008 Oct; 29(10):1726-31. PubMed ID: 18590783
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long-term behavioral effects of neonatal blockade of gastrin-releasing peptide receptors in rats: similarities to autism spectrum disorders.
    Merali Z; Presti-Torres J; Mackay JC; Johnstone J; Du L; St-Jean A; Levesque D; Kent P; Schwartsmann G; Roesler R; Schroder N; Anisman H
    Behav Brain Res; 2014 Apr; 263():60-9. PubMed ID: 24462726
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dexamethasone reverses the memory impairment induced by antagonism of hippocampal gastrin-releasing peptide receptors.
    Venturella R; Lessa D; Luft T; Roozendaal B; Schwartsmann G; Roesler R
    Peptides; 2005 May; 26(5):821-5. PubMed ID: 15808912
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Gastrin-releasing peptide receptor antagonist effects on an animal model of sepsis.
    Dal-Pizzol F; Di Leone LP; Ritter C; Martins MR; Reinke A; Pens Gelain D; Zanotto-Filho A; de Souza LF; Andrades M; Barbeiro DF; Bernard EA; Cammarota M; Bevilaqua LR; Soriano FG; Cláudio J; Moreira F; Roesler R; Schwartsmann G
    Am J Respir Crit Care Med; 2006 Jan; 173(1):84-90. PubMed ID: 16192447
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.